IA
NUVB icon

IFP Advisors’s Nuvation Bio NUVB Stock Holding History

IFP Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.3K Buy
3,788
+2,689
+245% +$15K ﹤0.01% 2887
2025
Q4 		$9.85K Hold
1,099
– – ﹤0.01% 3075
2025
Q3 		$4.07K Buy
1,099
+884
+411% +$2.41K ﹤0.01% 3360
2025
Q2 		$420 Buy
215
+165
+330% +$344 ﹤0.01% 4483
2025
Q1 		$88 Hold
50
– – ﹤0.01% 3889
2024
Q4 		$133 Buy
+50
New +$129 ﹤0.01% 3923

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IFP Advisors's NUVB Position: Q1 2026 in Review

IFP Advisors increased its Nuvation Bio (NUVB) stake by 245% in Q1 2026, buying an estimated $15K and bringing the position to 3,788 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

IFP Advisors first reported a position in NUVB in Q4 2024 and has held it in 6 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • IFP Advisors held 3,788 shares of Nuvation Bio worth $16.3K as of Q1 2026.
  • IFP Advisors bought 2,689 Nuvation Bio shares in Q1 2026, an estimated $15K.
  • Nuvation Bio made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #2887 holding.
  • IFP Advisors first reported a position in Nuvation Bio in Q4 2024 and has held it in 6 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.